NervGen Pharma Corp. Common stock
NGEN | NASDAQ
$1.39
+$0.02 (+1.46%)
Nov 2, 2026, 3:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -67.56M | -46.72M | -48.94M | -25.84M | -26.96M | -25.64M | -24.06M | -24.07M | -23.07M | -20.01M | -22.37M | -19.65M | -18.82M | -20.38M | -20.63M | -18.92M | -19.05M | -15.46M | -12.75M | -13.15M | -11.68M | -11.56M |
Depreciation & Amortization | 68.31K | 68.01K | 67.7K | 57.65K | 58.31K | 59.31K | 83.82K | 106.64K | 128.52K | 148.49K | 144.87K | 140.69K | 138.61K | 137.84K | 114.45K | 91.3K | 67.72K | 44.07K | 42.68K | 41.39K | 40.48K | 39.86K |
Stock-Based Compensation | 5.39M | 5.39M | 5.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.59M | -1.32M | 809.16K | 1.93M | 1.48M | 1.34M | 1M | 372.39K | 914.14K | 869.68K | -17.54K | 481.7K | -190.53K | 1.18M | 2.07M | 1.23M | 2.2M | 256.02K | 432.98K | 2.23M | 1.77M | 1.87M |
Other Non-Cash Items | 35.45M | 15.11M | 19.35M | 7.43M | 8.33M | 6.89M | 6.31M | 7.31M | 10.05M | 9.15M | 11.17M | 5.81M | 2.26M | 828.62K | 715.65K | 2.03M | 4.02M | 3.98M | 3.99M | 3.55M | 3.45M | 4M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.95M | -1.33M | 893.77K | 1.59M | 1.4M | 1.02M | 838.89K | 389.66K | 943.04K | 946.6K | -240.83K | 484.8K | -134.53K | 1.16M | 2.11M | 1.24M | 2.16M | 218.57K | 431.4K | 2.2M | 1.72M | 1.84M |
Operating Cash Flow | -29.6M | -27.47M | -23.23M | -16.76M | -17.18M | -17.67M | -16.83M | -16.26M | -11.94M | -9.76M | -11.29M | -13.21M | -16.55M | -18.25M | -17.69M | -15.56M | -12.81M | -11.22M | -8.29M | -7.36M | -6.48M | -5.68M |
Capital Expenditures | 4.18 | 4.18 | n/a | n/a | n/a | n/a | n/a | n/a | -2.67K | -5.61K | -5.61K | -5.61K | -8.61K | -15.66K | -21.05K | -21.05K | 24.16K | -8.13K | -2.75K | -2.74K | -42.27K | 4.01 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.55K | 2.55K | 2.55K | 2.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -20.44K | 4.99K | 21.53K | 134.54K | 142.86K | 117.51K | 92.42K | 33.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 100.93K | 100.93K | 100.93K | -33.62K | -42.02K | -33.61K | -33.61K | 6 | -126.95K | -135.35K | -135.35K | -135.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 80.48K | 105.92K | 122.45K | 100.92K | 100.84K | 83.89K | 58.81K | 33.59K | -129.62K | -140.96K | -138.42K | -138.42K | -6.06K | -13.11K | -21.04K | -21.04K | -18.12K | -50.41K | -45.03K | -45.03K | -42.28K | n/a |
Debt Repayment | -100.93K | -100.93K | -100.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -872.34K | -897.78K | -914.31K | -100.92K | -100.84K | -100.7K | -100.89K | -100.91K | -100.87K | -100.88K | -100.84K | -100.61K | -100.45K | -100.46K | -75.23K | -50.22K | -25.23K | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 102.69M | 27.27M | 25.71M | 7.35M | 6.62M | 1.96M | 22.73M | 22.5M | 22.3M | 22.44M | 765.93K | 770.13K | 20.38M | 22.69M | 22.45M | 34.05M | 17.17M | 19.12M | 19.69M | 8.05M | 10.61M | 8.43M |
Net Cash Flow | 73.4M | 5.32M | 8.45M | -10.54M | -11.1M | -17.15M | 4.05M | 6.36M | 9.91M | 12.38M | -10.42M | -12.29M | 4.44M | 4.47M | 4.93M | 18.34M | 4.01M | 8.01M | 11.39M | 908.32K | 4.45M | 3.05M |
Free Cash Flow | -29.6M | -27.47M | -23.23M | -16.76M | -17.18M | -17.67M | -16.83M | -16.26M | -11.94M | -9.77M | -11.3M | -13.22M | -16.56M | -18.26M | -17.71M | -15.58M | -12.78M | -11.23M | -8.29M | -7.36M | -6.52M | -5.68M |
Adj. Free Cash Flow | -34.99M | -32.87M | -28.63M | -16.76M | -17.18M | -17.67M | -16.83M | -16.26M | -11.94M | -9.77M | -11.3M | -13.22M | -16.56M | -18.26M | -17.71M | -15.58M | -12.78M | -11.23M | -8.29M | -7.36M | -6.52M | -5.68M |
Maintenance CapEx | -4.18 | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | -2.67K | -5.61K | -5.61K | -5.61K | -8.61K | -15.66K | -21.05K | -21.05K | -26.23K | -26.79K | -21.41K | -21.41K | -10.56K | -4.01 |
Growth CapEx | 8.36 | 8.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.38K | 18.66K | 18.66K | 18.67K | -31.72K | 8.02 |
Owner Earnings | -29.6M | -27.47M | -23.23M | -16.76M | -17.18M | -17.67M | -16.83M | -16.26M | -11.94M | -9.77M | -11.3M | -13.22M | -16.56M | -18.26M | -17.71M | -15.58M | -12.83M | -11.25M | -8.31M | -7.38M | -6.49M | -5.68M |
Add to Watchlist
Select watchlists to add or remove NGEN